Notably, TRIP13 has been shown to be overexpressed in several types of cancers, and its aberrant expression is involved in the malignant transformation of various types of cancer cells, including BrCa cells [48,49]. This evidence concerns the gene TRIP13 and invasive breast carcinoma.